Results 51 to 60 of about 1,396,034 (289)

American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach.

Endocrine Practice, 2020
OBJECTIVE The aim of this Disease State Clinical Review is to provide a practical approach to patients with newly diagnosed adrenocortical carcinoma, as well as to follow-up and management of patients with persistent or recurrent disease.
K. Kiseljak-Vassiliades, I. Bancos, A. Hamrahian, M. Habra, A. Vaidya, A. Levine, T. Else   +6 more
semanticscholar   +1 more source

Differential diagnosis of adrenal masses by chemical shift and dynamic gadolinium enhanced MR imaging. [PDF]

, 2003
Chemical shift MRI is widely used for identifying adenomas, but it is not a perfect method. We determined whether combined dynamic MRI methods can lead to improved diagnostic accuracy.
Akaki, Shiro, Hiraki, Yoshio, Sasai, Nobuya, Sei, Tetsuro, Togami, Izumi, Tsunoda, Masatoshi   +5 more
core   +1 more source

Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions

Cancers, 2020
Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with high risk of recurrence despite macroscopically complete surgical resection.
Sara Bedrose, Marilyne Daher, Lina Altameemi, M. Habra   +3 more
semanticscholar   +1 more source

Surgical approach to an adrenocortical carcinoma with right atrial extension in a nine-year old male: Our experience

Journal of Pediatric Surgery Case Reports, 2020
Adrenocortical carcinoma with intracaval and intra atrial extension is an extremely rare occurrence in the pediatric population. We report the case of a nine‐year‐old male who presented to our outpatient department with facial swelling, weight gain, and ...
Ayesha Saleem, Sarah Jeelani, Zain Baig, Muhammad Arshad   +3 more
doaj   +1 more source

Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma

IJU Case Reports, 2023
Introduction Advanced adrenocortical carcinoma has a poor prognosis and is treated with chemotherapy that includes mitotane with etoposide, doxorubicin, and cisplatin as first‐line therapy.
Masaya Senda, Kohei Hashimoto, Tetsuya Shindo, Ko Kobayashi, Toshiaki Tanaka, Naoya Masumori   +5 more
doaj   +1 more source

Virilizing adrenocortical carcinoma in a child: A rare enigma

Indian Journal of Endocrinology and Metabolism, 2012
Adrenocortical carcinomas are rare tumors with an incidence of one to two cases per million population and are still more rarer in the pediatric age group.
Varuna Sipayya, Yogesh K Yadav, Rashmi Arora, Uma Sharma, Kusum Gupta   +4 more
doaj   +1 more source

Long‐term survival of a patient with refractory advanced adrenocortical carcinoma after combination chemotherapy with paclitaxel and carboplatin plus mitotane

IJU Case Reports, 2022
Introduction The prognosis of patients with unresectable adrenocortical carcinoma is poor. Mitotane is the first‐line treatment for this disease, and etoposide/doxorubicin/cisplatin/mitotane therapy is recommended as first‐line chemotherapy in ...
Yuki Kobayakawa, Shuzo Hamamoto, Hideyuki Kamisawa, Shinsuke Okada, Kazumi Taguchi, Taku Naiki, Atsushi Okada, Keiichi Tozawa, Takahiro Yasui   +8 more
doaj   +1 more source

Robot-Assisted Laparoscopic Adrenalectomy for Rare Myxoid Adrenocortical Carcinoma

Case Reports in Urology, 2019
Background. Surgical resection remains the standard treatment for adrenocortical carcinoma. Higher rates of local and peritoneal recurrence have been reported with the laparoscopic approach compared to open resection, although the evidence is limited.
Grant Johnson, Kiran Thalody, Umesh Kapur, Thai T. Nguyen   +3 more
doaj   +1 more source

Adrenocortical carcinoma with extension to the inferior vena cava and right atrium: 20-month-old girl with TP53 mutation

Radiology Case Reports, 2015
A 20-month-old female presented with respiratory distress and a right adrenal mass extending into the inferior vena cava and right atrium. The mass was initially thought to be neuroblastoma. Pathology later revealed adrenocortical carcinoma.
Terry L. Levin, MD, Walter E. Berdon, MD, Daniel Weiser, MD, Raul C. Ribeiro, MD   +3 more
doaj   +1 more source

Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy

IJU Case Reports, 2020
Introduction Adrenocortical carcinoma is a rare malignant tumor with an unfavorable prognosis in the advanced stage for which second‐/third‐line chemotherapy is not well established.
Akinaru Yamamoto, Yasutomo Nakai, Toshiki Oka, Tomohiro Kanaki, Yoshiyuki Yamamoto, Akira Nagahara, Masashi Nakayama, Ken‐ichi Kakimoto, Kazuo Nishimura   +8 more
doaj   +1 more source